Amsterdam-based health-tech startup Ditto has secured €7.6 million in funding to accelerate its mission of bringing AI-powered medical appointment summaries directly to patients. The company, which specializes in generating concise, AI-generated summaries of doctor visits, announced the funding round led by Heal Capital, with additional participation from Rubio Impact Ventures. Notably, Chris Oomen, chair of Optiverder, also joined the investment group.
Enhancing Patient Engagement Through AI
Ditto’s technology aims to bridge a critical gap in healthcare communication by ensuring patients leave appointments with a clear understanding of their consultation. The platform automatically transcribes and summarizes medical discussions, making it easier for patients to recall important information and follow up on treatment plans. This is particularly valuable in a healthcare landscape where patients often leave appointments feeling confused or overwhelmed by medical jargon.
Strategic Expansion Plans
The newly acquired funding will support Ditto’s expansion into key European markets, including Germany, the UK, and Spain. This strategic move underscores the company’s ambition to scale its impact across the continent, where healthcare systems are increasingly recognizing the value of digital tools in improving patient outcomes and engagement. The company’s growth trajectory aligns with broader trends in digital health, where AI is being leveraged to streamline communication and enhance care delivery.
With this latest funding, Ditto is well-positioned to deepen its product offering and solidify its role in the evolving digital health ecosystem. As more patients and providers embrace AI-driven solutions, Ditto’s focus on usability and accessibility could prove instrumental in shaping the future of patient-centered care.
